Full-Time

Policy & Reimbursement – Senior Director

Posted on 12/7/2024

GRAIL

GRAIL

1,001-5,000 employees

Blood tests for early cancer detection

Biotechnology
Healthcare

Compensation Overview

$223k - $297kAnnually

+ Bonus + Incentive Plan + Long-term Incentive Plan

Senior, Expert

Washington, DC, USA

This position is based in GRAIL’s Washington, DC office.

Category
Financial Consulting
Legal Consulting
Consulting
Required Skills
Public Policy
Data Analysis

You match the following GRAIL's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree required; advanced degree preferred.
  • 12+ years of experience in public policy at the national or state level, with a focus on healthcare product coverage and payment.
  • Proven leadership in navigating complex policy issues and implementing strategic reimbursement plans.
  • Extensive knowledge of public program coverage, including Medicare and Medicaid.
  • Strong capability to develop and maintain robust internal and external relationships, enhancing the company’s policy positions.
  • Exceptional interpersonal, communication, and organizational skills.
Responsibilities
  • Develop and maintain a strategic plan for proactive engagement with CMS, the Office of the Administrator, the Center for Clinical Standards and Quality, and the Center for Medicare.
  • Lead engagement with CMS and implementation of coverage workstreams, including coverage policy for multi-cancer early detection.
  • Collaborate closely with the SVP and company leadership to execute engagement strategies that promote comprehensive coverage and meaningful reimbursement.
  • Navigate CMS regulatory frameworks and leverage CAG processes to advocate for the inclusion and support of our products in public insurance programs.
  • Monitor external policy developments and industry trends to identify opportunities and mitigate risks.
  • Lead the development and execution of policy strategies on federal and state legislative and regulatory issues.
  • Produce and spearhead comment letters on behalf of GRAIL and actively participate in policy discussions to align on company policy positions.
  • Support government affairs and strategic alliances through policy research projects and material development.
  • Engage with industry trade associations to promote and align on company policy priorities.
  • Develop and maintain processes to ensure organizational awareness of government policies affecting GRAIL and respond to such policies in collaboration with internal government affairs and business partners.
  • Manage/direct external consultants on GRAIL public payer reimbursement activities.
  • Collaborate with the VP of Market Access to ensure our cross-pollination of public and private payer strategies, including identifying opportunities for coverage.
  • Coordinate with internal stakeholders across Commercial, HEOR, Medical Affairs, Regulatory Affairs, and Marketing to enhance support for product coverage and reimbursement strategies.
  • Collaborate with HEOR colleagues on analytics development to demonstrate the value of early cancer detection for Medicare and other public payers.
  • Work cross-functionally to support evidence-generation planning for coverage.
  • Acts as a resource on reimbursement and related health policy issues to internal business areas, industry partners, and regulatory agencies.
Desired Qualifications
  • Understanding of the molecular diagnostics and screening market is preferred.
  • Experience with health outcomes research studies is advantageous.
  • Innovative, energetic, and resourceful with a diplomatic and intuitive approach. Commitment to communal success and the idea that we succeed only by helping teammates succeed.

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by conducting large-scale clinical studies to ensure the effectiveness and reliability of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Company Stage

Acquired

Total Funding

$1.8B

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

4%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaborations with platforms like Function Health expand Galleri test accessibility.
  • Revenue from Galleri grew 52% year-over-year, indicating strong market demand.
  • GRAIL's technology aligns with trends in personalized and preventative medicine.

What critics are saying

  • Potential overdiagnosis could impact the perceived value of GRAIL's tests.
  • Significant net losses may affect investor confidence and long-term sustainability.
  • High test costs may limit accessibility in markets with less healthcare funding.

What makes GRAIL unique

  • GRAIL uses high-intensity sequencing for early cancer detection via blood tests.
  • The Galleri test screens for over 50 cancers with a single blood draw.
  • GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

INACTIVE